Bisphenol S instead of Bisphenol A: Toxicokinetic investigations in the ovine materno-feto-placental unit. (November 2018)

• Record Type: Journal Article
• Authors: Grandin, Flore C.; Lacroix, Marlène Z.; Gayrard, Véronique; Gauderat, Glenn; Mila, Hanna; Toutain, Pierre-Louis; Picard-Hagen, Nicole
• Is Part Of: Environment international. Volume 120(2018)
• Page Start: 584
• Page End: 592
• Publication Date: 2018-11
• Subjects: BPS Bisphenol S -- BPA Bisphenol A -- BPSG Bisphenol S glucuronide -- BPAG Bisphenol A glucuronide -- TK Toxicokinetic -- LLOQ lower limit of quantification -- AUC Area under curve -- MRT Mean residence time -- t1/2 half-time -- Cl clearance -- Vss steady state volume of distribution; Bisphenol S -- Bisphenol S Glucuronide -- Toxicokinetic -- Fetal exposure -- Bisphenol A analogue; Environmental protection -- Periodicals; Environmental health -- Periodicals; Environmental monitoring -- Periodicals; Environmental Monitoring -- Periodicals; Environnement -- Protection -- Périodiques; Hygiène du milieu -- Périodiques; Environnement -- Surveillance -- Périodiques; Environmental health; Environmental monitoring; Environmental protection; Periodicals; 333.705
• DOI: 10.1016/j.envint.2018.08.019
• Languages: English
• ISSNs: 0160-4120

Abstract

Abstract: Bisphenol S (BPS) is widely used as a substitute for Bisphenol A in consumer products. Despite its potential endocrine-disrupting effects and widespread exposure, toxicokinetic data, particularly during the critical period of pregnancy, are not available for BPS. The objectives of our study were to evaluate the mechanisms determining fetal exposure to BPS and to BPS glucuronide (BPSG) and to compare them with those prevailing for BPA. The disposition of BPS and BPSG was evaluated in the materno-fetal unit of the catheterized pregnant ewe model, following intravenous administrations of BPS and BPSG to mothers and their fetuses. In a second experiment, the rate of BPS accumulation in the fetal compartment was determined under steady-state conditions after repeated intravenous BPS administrations to the mother. In the maternal compartment, BPS was mainly metabolized into BPSG and totally eliminated in urine. Only 0.40% of the maternal dose was transferred to the fetus. However, once in the fetal compartment, 26% of the fetal dose was rapidly eliminated through placental transfer, while 46% of BPS was metabolized into BPSG which remained trapped in the fetal compartment. Thus, the elimination of BPSG from the fetal compartment required its back-conversion into bioactive BPS, leading to an 87% enhancement of the fetal BPS exposure. Our findings demonstrate that, despite the low materno-fetal placental transfer of BPS, this substitute for BPA is able to accumulate in the fetal compartment after repeated maternal exposure, leading to chronic fetal exposure to BPS in a range of concentrations similar to those of BPA. Graphical abstract: Unlabelled Image Highlights: Fetal sheep was used to evaluate BPS and BPSG toxicokinetic parameters. The materno-fetal placental transfer of BPS is limited, ten times lower than for BPA. BPS is able to accumulate in the fetal compartment after repeated maternal exposure. The chronic fetal internal exposure to BPS is similar to that of BPA.